Treatment of non-infectious retinal vasculitis

Ther Adv Ophthalmol. 2023 Feb 13:15:25158414231152761. doi: 10.1177/25158414231152761. eCollection 2023 Jan-Dec.

Abstract

Retinal vasculitis (RV) refers to an entity in which the retinal vasculature is inflamed, frequently with indications of inflammation elsewhere in the eye. Non-infectious RV can be idiopathic or associated with systemic disease, ocular conditions, and malignancy. It can also be classified based on the vessel affected: artery, vein, or both. Due to the lack of strong evidence-based treatment trials and algorithms for RV, physicians must often rely on their experience, which creates great variability in treating this entity. This article provides an overview of various treatment modalities used in the management of non-infectious RV, with a focus on immunomodulatory therapies. We outline a potential stepwise approach of starting with steroids to control the acute inflammation and subsequently changing to immunomodulatory therapy (IMT) for long-term treatment.

Keywords: TNF-α inhibitors; biologics; corticosteroids; immunomodulators; inflammatory eye disease; non-infectious retinal vasculitis; ocular inflammatory disease.

Publication types

  • Review